These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2257558)

  • 1. Hematopoietic growth factors in oncology.
    Mertelsmann R; Lindemann A; Oster W; Gamm H; Kolbe K; Herrmann F
    Cancer Detect Prev; 1990; 14(6):613-6. PubMed ID: 2257558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M; Ganser A
    Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology].
    Karthaus M; Ganser A
    Zentralbl Gynakol; 1997; 119(12):585-96. PubMed ID: 9483809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hematopoietic growth factors in transfusion medicine.
    Whitsett CF
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):23-68. PubMed ID: 7737944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
    Barge AJ
    Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of hematopoietic growth factors--general principles].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1996; 49(5-6):185-93. PubMed ID: 8692093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-3 in hematology and oncology: current state of knowledge and future directions.
    Mangi MH; Newland AC
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):87-95. PubMed ID: 10515681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical use of hematopoietic growth factors.
    Appelbaum FR
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid hemopoietic growth factors. Review article.
    Vrhovac R; Kusec R; Jaksić B
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):241-52. PubMed ID: 8314653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic growth factors.
    Williams ME; Quesenberry PJ
    Hematol Pathol; 1992; 6(3):105-24. PubMed ID: 1429340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia.
    Wodnar-Filipowicz A; Chklovskaia E; Manz CY; Lyman SD; Nissen C
    Exp Hematol; 1997 Jul; 25(7):573-81. PubMed ID: 9216732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
    Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
    Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
    J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic growth factors for the treatment of inherited cytopenias.
    Zeidler C; Welte K
    Semin Hematol; 2007 Jul; 44(3):133-7. PubMed ID: 17631177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hematopoietic growth factors].
    Zwierzina H; Hoffmann S; Schmalzl F; Braunsteiner H
    Wien Med Wochenschr; 1991; 141(14):311-20. PubMed ID: 1949830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.